Dror Ortho-Design, Inc.

S-1/A amended

Dror Ortho-Design, Inc. filed an S-1/A registration statement for an IPO, amending previous disclosures. The filing includes details about the offering of common stock, prefunded warrants, and underwriter warrants, with a focus on a 1-for-550 reverse stock split. The company aims to list on Nasdaq Capital Market and highlights risks related to its early-stage operations, regulatory compliance, and market competition.

S-1/A amended

Dror Ortho-Design, Inc. is conducting an IPO offering up to 2,020,203 shares of common stock, prefunded warrants, and underwriter warrants. The filing includes details about the reverse stock split, underwriting terms, and listing plans on the NYSE American. The prospectus highlights risks related to market acceptance, regulatory compliance, and operational challenges.

S-1/A amended

Dror Ortho-Design, Inc. filed an S-1/A registration statement to delay the effective date of its IPO until a further amendment is filed. The filing includes details about a 1-for-450 reverse stock split, securities offerings (common stock, prefunded warrants, and underwriter warrants), and underwriting terms. The company anticipates listing on the NYSE American post-offering, pending approval.

S-1 filed

Dror Ortho-Design, Inc. is conducting an IPO to offer up to [●] shares of common stock, prefunded warrants, and underwriter warrants. The offering includes a 1-for-[●] reverse stock split, with shares expected to trade on the NYSE American post-offering. The company aims to raise capital through the sale of securities, with the final public offering price determined by negotiations with underwriters. The filing highlights risks related to market acceptance, regulatory compliance, and operational challenges.

DRS filed

Dror Ortho-Design, Inc. has submitted a confidential draft registration statement (DRS) for an upcoming IPO, outlining the offering of up to shares of common stock, prefunded warrants, and underwriter warrants. The filing indicates plans for a 1-for-[●] reverse stock split and intends to list on Nasdaq, contingent on approval. The company remains in the development stage, with no revenue, and faces significant risks related to market acceptance, regulatory compliance, and competition.

EFFECT effective

Dror Ortho-Design, Inc. has filed a Form S-1 registration statement to register the resale of 2,304,316,461 shares of common stock, including shares from a private placement, convertible preferred stock, and warrants. The offering is structured under a registration rights agreement, with proceeds from warrant exercises intended for general corporate purposes. The company, formerly Novint Technologies, Inc., rebranded after a share exchange with Dror Ortho-Design Ltd., transitioning to orthopedic design as its sole business. The shares are currently quoted on the OTC Pink Market, with no underwriter involved in the offering.

S-1/A amended

Dror Ortho-Design, Inc. is registering shares of common stock, convertible preferred stock, and warrants for resale by selling securityholders. The offering follows a share exchange and private placement, with the company transitioning from Novint Technologies, Inc. to focus on the orthopedic design business of Private Dror. The shares include common stock, conversion shares from preferred stock, and warrant shares, with no proceeds going to the company directly.

S-1/A amended

Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) is registering shares for resale under a shelf registration statement, including common stock, convertible preferred stock, and warrants from a private placement and share exchange. The offering follows a share exchange with Private Dror, resulting in the company's name change and transition to Ortho-Design's business. The registration satisfies registration rights agreements, with proceeds from warrant exercises used for general corporate purposes. The company's stock is currently quoted on the OTC Pink market.

S-1 filed

Dror Ortho-Design, Inc. filed an S-1 registration statement for potential public offering of securities. The filing includes financial data, capital structure details, and corporate governance information. The company appears to be reactivating a registration process previously withdrawn under RW form by Novint Technologies, Inc.

RW withdrawn

Novint Technologies, Inc. has withdrawn its Registration Statement on Form 10-12G/A, filed on January 22, 2020, following previous withdrawal requests for an earlier Form 10-12G filing in November 2019. The company cites unresolved SEC comments as a key reason for the withdrawal, indicating ongoing regulatory challenges and the intent to resubmit a revised registration statement.

RW withdrawn

Novint Technologies, Inc. withdrew its registration statement on Form 10, filed in November 2019, citing unresolved SEC comments. The company aims to refile a revised registration statement after addressing these issues, indicating ongoing regulatory challenges prior to the IPO process.

EFFECT effective

The current filing is a Notice of Effectiveness for Novint Technologies Inc., dated August 10, 2007, as a Post-Effective Amendment (POS AM), following a previous filing on June 18, 2007 as an SB-2 form. The filings indicate regulatory clearance for securities offerings, with updated effectiveness dates and form types.

EFFECT effective

The filing represents a Notice of Effectiveness for Dror Ortho-Design, Inc. (listed as NOVINT TECHNOLOGIES INC in the document) for Form SB-2, effective June 18, 2007. This appears to be the company's initial filing, as no previous filing is noted.